TY  - GEN
AU  - Dearnaley,D P
AU  - Hall,E
AU  - Lawrence,D
AU  - Huddart,R A
AU  - Eeles,R
AU  - Nutting,C M
AU  - Gadd,J
AU  - Warrington,A
AU  - Bidmead,M
AU  - Horwich,A
TI  - Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
SN  - 0007-0920
PY  - 2005///0330
KW  - Adenocarcinoma
KW  - radiotherapy
KW  - Aged
KW  - Androgen Antagonists
KW  - therapeutic use
KW  - Cyproterone
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Pilot Projects
KW  - Prostate-Specific Antigen
KW  - blood
KW  - Prostatic Neoplasms
KW  - Radiation Injuries
KW  - Radiotherapy Dosage
KW  - Radiotherapy, Conformal
KW  - adverse effects
KW  - Rectum
KW  - radiation effects
KW  - Treatment Outcome
KW  - Urinary Bladder
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.bjc.6602301
ER  -